REICHMAN AMIR (Chief Executive Officer) received a stock award from SCINAI IMMUNOTHERAPEUTICS LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/18/2026ACC: 0001178913-26-003259
DirectorOfficer· Chief Executive Officer
Since Jan 2023
+400M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
400M acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+400M
Price / share
—
Trade value
—
% of position
128.4%
6/16/2026
311.64M→711.64M
Total
Net shares
+400M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/16/2026 | A · Award | +400M | — | — | 128.4% | 311.64M | 711.64M |
| Total | +400M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported